Prospective modulation of platelet function and volumes by aspirin and dipyridamole in an at‐risk pregnancy
- 1 January 1992
- journal article
- case report
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 99 (1) , 75-80
- https://doi.org/10.1111/j.1471-0528.1992.tb14397.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trialThe Lancet, 1991
- Increased platelet turnover in a patient with previous recurrent pre‐eclampsia and failure of aspirin therapy. Case reportBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Histological study of the materno-embryonic interface in spontaneous abortionPlacenta, 1990
- Equivalent inhibition of in vivo platelet function by low dose and high dose aspirin treatmentProstaglandins, Leukotrienes & Essential Fatty Acids, 1990
- Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiencyAmerican Journal of Obstetrics and Gynecology, 1988
- LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAEThe Lancet, 1986
- PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPYThe Lancet, 1985
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope techniqueThrombosis Research, 1979
- Uteroplacental vascular pathologyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1975